Alpha1H

LUND, Sweden, June 17, 2026 Hamlet BioPharma AB has reached a major clinical development milestone with the successful completion...

SAN DIEGO, California, June 22, 2026 Phanes Therapeutics has announced the successful completion of patient enrollment in its Phase...

LUND, Sweden, June 22, 2026 Hamlet BioPharma AB has announced a significant expansion of its U.S. clinical development program...